Sort by
Refine Your Search
-
genetic screens in Primary and cell line models of T-cell lymphomas and characterize their oncogenic dependencies, and functionally validate them using CRISPR-based genetic perturbation approaches. Through
-
manufacturing procedures and the requirement for lymphodepleting chemotherapy, which together limit patient access. Here, we propose an in vivo engineering strategy based on targeted lipid nanoparticles (tLNPs
Searches related to model driven engineering
Enter an email to receive alerts for model-driven-engineering positions